{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:58:24Z","timestamp":1790132304750,"version":"4.0.1"},"publisher-location":"Cham","reference-count":85,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030674519","type":"print"},{"value":"9783030674526","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-67452-6_2","type":"book-chapter","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T02:11:16Z","timestamp":1634609476000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mechanisms of Immune Evasion by Ebola Virus"],"prefix":"10.1007","author":[{"given":"Suchita","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"issue":"suppl 3","key":"2_CR1","doi-asserted-by":"publisher","first-page":"S957","DOI":"10.1093\/infdis\/jir326","volume":"204","author":"P Aleksandrowicz","year":"2011","unstructured":"Aleksandrowicz P et al (2011) Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J Infect Dis 204(suppl 3):S957\u2013S967","journal-title":"J Infect Dis"},{"issue":"3","key":"2_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1034\/j.1600-0854.2000.010307.x","volume":"1","author":"M Babst","year":"2000","unstructured":"Babst M et al (2000) Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 1(3):248\u2013258","journal-title":"Traffic"},{"issue":"4","key":"2_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/7422","volume":"5","author":"S Baize","year":"1999","unstructured":"Baize S et al (1999) Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 5(4):423\u2013426","journal-title":"Nat Med"},{"issue":"5","key":"2_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1084\/jem.20011500","volume":"195","author":"S Bavari","year":"2002","unstructured":"Bavari S et al (2002) Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 195(5):593\u2013602","journal-title":"J Exp Med"},{"key":"2_CR5","volume-title":"Microbial pathogenesis: infection and immunity","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya S (2013) Modulation of type I interferon response by RNA viruses. In: Microbial pathogenesis: infection and immunity, 1st edn. Landes Bioscience and Springer Science, Berlin. http:\/\/www.landesbioscience.com\/curie\/chapter\/5424\/","edition":"1"},{"key":"2_CR6","unstructured":"Bhattacharyya S (2007) Exploring filoviral entry. http:\/\/hdl.handle.net\/10027\/13048"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1743-422X-8-11","volume":"8","author":"S Bhattacharyya","year":"2011","unstructured":"Bhattacharyya S, Hope TJ (2011) Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum. Virol J 8:11","journal-title":"Virol J"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"487585","DOI":"10.1155\/2013\/487585","volume":"2013","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya S, Hope TJ (2013) Cellular factors implicated in filovirus entry. Adv Virol 2013:487585","journal-title":"Adv Virol"},{"issue":"1","key":"2_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.virol.2010.02.015","volume":"401","author":"S Bhattacharyya","year":"2010","unstructured":"Bhattacharyya S et al (2010) Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 401(1):18\u201328","journal-title":"Virology"},{"issue":"1","key":"2_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2011.07.018","volume":"419","author":"S Bhattacharyya","year":"2011","unstructured":"Bhattacharyya S et al (2011) Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions. Virology 419(1):1\u20139","journal-title":"Virology"},{"issue":"12","key":"2_CR11","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.3390\/v4123647","volume":"4","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya S et al (2012) Endocytic pathways involved in filovirus entry: advances, implications and future directions. Viruses 4(12):3647\u20133664","journal-title":"Viruses"},{"issue":"2","key":"2_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.chom.2013.07.005","volume":"14","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya S et al (2013) Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host Microbe 14(2):136\u2013147","journal-title":"Cell Host Microbe"},{"issue":"18","key":"2_CR13","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","volume":"287","author":"L Borio","year":"2002","unstructured":"Borio L et al (2002) Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287(18):2391\u20132405","journal-title":"JAMA"},{"issue":"11","key":"2_CR14","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1086\/379199","volume":"188","author":"CM Bosio","year":"2003","unstructured":"Bosio CM et al (2003) Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis 188(11):1630\u20131638","journal-title":"J Infect Dis"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cellimm.2017.11.009","volume":"324","author":"JH Bradley","year":"2018","unstructured":"Bradley JH et al (2018) Ebola virus secreted glycoprotein decreases the anti-viral immunity of macrophages in early inflammatory responses. Cell Immunol 324:24\u201332","journal-title":"Cell Immunol"},{"issue":"10","key":"2_CR16","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1128\/jvi.74.10.4933-4937.2000","volume":"74","author":"SY Chan","year":"2000","unstructured":"Chan SY et al (2000) Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol 74(10):4933\u20134937","journal-title":"J Virol"},{"issue":"8","key":"2_CR17","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1128\/JVI.75.8.4014-4018.2001","volume":"75","author":"N Chazal","year":"2001","unstructured":"Chazal N et al (2001) Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. J Virol 75(8):4014\u20134018","journal-title":"J Virol"},{"issue":"1","key":"2_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1053\/jinf.1999.0603","volume":"40","author":"R Colebunders","year":"2000","unstructured":"Colebunders R, Borchert M (2000) Ebola haemorrhagic fever\u2014a review. J Infect 40(1):16\u201320","journal-title":"J Infect"},{"issue":"Suppl 1","key":"2_CR19","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1086\/514284","volume":"179","author":"SF Dowell","year":"1999","unstructured":"Dowell SF et al (1999) Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epid\u00e9mies \u00e0 Kikwit. J Infect Dis 179(Suppl 1):S87\u2013S91","journal-title":"J Infect Dis"},{"issue":"suppl_5","key":"2_CR20","doi-asserted-by":"publisher","first-page":"S672","DOI":"10.1093\/infdis\/jiy304","volume":"218","author":"J Dyall","year":"2018","unstructured":"Dyall J et al (2018) Identification of combinations of approved drugs with synergistic activity against Ebola virus in cell cultures. J Infect Dis 218(suppl_5):S672\u2013S678","journal-title":"J Infect Dis"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3389\/fimmu.2018.01428","volume":"9","author":"A Edri","year":"2018","unstructured":"Edri A et al (2018) The Ebola-glycoprotein modulates the function of natural killer cells. Front Immunol 9:1428","journal-title":"Front Immunol"},{"issue":"4","key":"2_CR22","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1128\/jcm.16.4.704-708.1982","volume":"16","author":"LH Elliott","year":"1982","unstructured":"Elliott LH et al (1982) Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol 16(4):704\u2013708","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0042-6822(85)90236-3","volume":"147","author":"LH Elliott","year":"1985","unstructured":"Elliott LH et al (1985) Descriptive analysis of Ebola virus proteins. Virology 147(1):169\u2013176","journal-title":"Virology"},{"issue":"10","key":"2_CR24","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1128\/JVI.76.10.5266-5270.2002","volume":"76","author":"CJ Empig","year":"2002","unstructured":"Empig CJ, Goldsmith MA (2002) Association of the caveola vesicular system with cellular entry by filoviruses. J Virol 76(10):5266\u20135270","journal-title":"J Virol"},{"issue":"6","key":"2_CR25","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1128\/JVI.01160-10","volume":"85","author":"G Fabozzi","year":"2011","unstructured":"Fabozzi G et al (2011) Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J Virol 85(6):2512\u20132523","journal-title":"J Virol"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","volume":"377","author":"H Feldmann","year":"2010","unstructured":"Feldmann H, Geisbert TW (2010) Ebola haemorrhagic fever. Lancet 377:849\u2013862","journal-title":"Lancet"},{"issue":"2","key":"2_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1006\/viro.1994.1147","volume":"199","author":"H Feldmann","year":"1994","unstructured":"Feldmann H et al (1994) Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 199(2):469\u2013473","journal-title":"Virology"},{"issue":"4","key":"2_CR28","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/jvi.70.4.2208-2214.1996","volume":"70","author":"H Feldmann","year":"1996","unstructured":"Feldmann H et al (1996) Filovirus-induced endothelial leakage triggered by infected monocytes\/macrophages. J Virol 70(4):2208\u20132214","journal-title":"J Virol"},{"issue":"8","key":"2_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nri1154","volume":"3","author":"H Feldmann","year":"2003","unstructured":"Feldmann H et al (2003) Ebola virus: from discovery to vaccine. Nat Rev Immunol 3(8):677\u2013685","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 4","key":"2_CR30","doi-asserted-by":"publisher","first-page":"S777","DOI":"10.1093\/clinids\/11.Supplement_4.S777","volume":"11","author":"JH Gear","year":"1989","unstructured":"Gear JH (1989) Clinical aspects of African viral hemorrhagic fevers. Rev Infect Dis 11(Suppl 4):S777\u2013S782","journal-title":"Rev Infect Dis"},{"issue":"2\u20133","key":"2_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0168-1702(95)00080-1","volume":"39","author":"TW Geisbert","year":"1995","unstructured":"Geisbert TW, Jahrling PB (1995) Differentiation of filoviruses by electron microscopy. Virus Res 39(2\u20133):129\u2013150","journal-title":"Virus Res"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41564-018-0227-2","volume":"3","author":"T Goldstein","year":"2018","unstructured":"Goldstein T et al (2018) The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses. Nat Microbiol 3:1084\u20131089","journal-title":"Nat Microbiol"},{"issue":"Suppl 2","key":"2_CR33","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1093\/infdis\/jiv125","volume":"212","author":"JK Gustin","year":"2015","unstructured":"Gustin JK et al (2015) Ebola virus glycoprotein promotes enhanced viral egress by preventing Ebola VP40 from associating with the host restriction factor BST2\/tetherin. J Infect Dis 212(Suppl 2):S181\u2013S190","journal-title":"J Infect Dis"},{"issue":"3","key":"2_CR34","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1128\/JVI.77.3.1793-1800.2003","volume":"77","author":"Z Han","year":"2003","unstructured":"Han Z et al (2003) Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding. J Virol 77(3):1793\u20131800","journal-title":"J Virol"},{"issue":"4","key":"2_CR35","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1128\/JVI.73.4.3491-3496.1999","volume":"73","author":"BH Harcourt","year":"1999","unstructured":"Harcourt BH et al (1999) Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells. J Virol 73(4):3491\u20133496","journal-title":"J Virol"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1128\/JVI.02344-07","volume":"82","author":"AL Hartman","year":"2008","unstructured":"Hartman AL et al (2008) Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of Ebola virus. J Virol 82:2699\u20132704","journal-title":"J Virol"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/d41586-018-05205-x","volume":"557","author":"EC Hayden","year":"2018","unstructured":"Hayden EC (2018) Experimental drugs poised for use in Ebola outbreak. Nature 557:475\u2013476","journal-title":"Nature"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.virol.2017.06.002","volume":"509","author":"F He","year":"2017","unstructured":"He F et al (2017) Ebolavirus protein VP24 interferes with innate immune responses by inhibiting interferon-\u03bb1 gene expression. Virology 509:23\u201334","journal-title":"Virology"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","volume":"389","author":"AM Henao-Restrepo","year":"2017","unstructured":"Henao-Restrepo AM et al (2017) Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial. Lancet 389:505\u2013518","journal-title":"Lancet"},{"issue":"3","key":"2_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0165-2478(01)00327-3","volume":"80","author":"LE Hensley","year":"2002","unstructured":"Hensley LE et al (2002) Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 80(3):169\u2013179","journal-title":"Immunol Lett"},{"issue":"3","key":"2_CR41","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1128\/JVI.79.3.1898-1905.2005","volume":"79","author":"T Hoenen","year":"2005","unstructured":"Hoenen T et al (2005) VP40 octamers are essential for Ebola virus replication. J Virol 79(3):1898\u20131905","journal-title":"J Virol"},{"issue":"14","key":"2_CR42","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1128\/JVI.00051-06","volume":"80","author":"T Hoenen","year":"2006","unstructured":"Hoenen T et al (2006) Infection of naive target cells with virus-like particles: implications for the function of Ebola virus VP24. J Virol 80(14):7260\u20137264","journal-title":"J Virol"},{"issue":"1","key":"2_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1128\/JVI.01278-09","volume":"85","author":"CL Hunt","year":"2011","unstructured":"Hunt CL et al (2011) The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. J Virol 85(1):334\u2013347","journal-title":"J Virol"},{"issue":"1\u20132","key":"2_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000149300","volume":"18","author":"MP Kiley","year":"1982","unstructured":"Kiley MP et al (1982) Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology 18(1\u20132):24\u201332","journal-title":"Intervirology"},{"issue":"2","key":"2_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0042-6822(86)90127-3","volume":"149","author":"MP Kiley","year":"1986","unstructured":"Kiley MP et al (1986) Conservation of the 3\u2032 terminal nucleotide sequences of Ebola and Marburg virus. Virology 149(2):251\u2013254","journal-title":"Virology"},{"issue":"1","key":"2_CR46","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1073\/pnas.0910547107","volume":"107","author":"CR Kimberlin","year":"2010","unstructured":"Kimberlin CR et al (2010) Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci U S A 107(1):314\u2013319","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2_CR47","doi-asserted-by":"publisher","first-page":"e1005937","DOI":"10.1371\/journal.ppat.1005937","volume":"12","author":"RN Kirchdoerfer","year":"2016","unstructured":"Kirchdoerfer RN et al (2016) The Ebola virus VP30-NP interaction is a regulator of viral RNA synthesis. PLoS Pathog 12(10):e1005937","journal-title":"PLoS Pathog"},{"issue":"3830","key":"2_CR48","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1126\/science.160.3830.888","volume":"160","author":"RE Kissling","year":"1968","unstructured":"Kissling RE et al (1968) Agent of disease contracted from green monkeys. Science 160(3830):888\u2013890","journal-title":"Science"},{"key":"2_CR49","first-page":"1229","volume":"159","author":"JH Kuhn","year":"2013","unstructured":"Kuhn JH et al (2013) Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch Virol 159:1229\u20131237","journal-title":"Arch Virol"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/438575a","volume":"438","author":"EM Leroy","year":"2005","unstructured":"Leroy EM et al (2005) Fruit bats as reservoirs of Ebola virus. Nature 438:575\u2013576","journal-title":"Nature"},{"issue":"1","key":"2_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.chom.2013.06.010","volume":"14","author":"P Luthra","year":"2013","unstructured":"Luthra P et al (2013) Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 14(1):74\u201384","journal-title":"Cell Host Microbe"},{"issue":"12","key":"2_CR52","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/nm1201-1313","volume":"7","author":"J Martin-Serrano","year":"2001","unstructured":"Martin-Serrano J et al (2001) HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med 7(12):1313\u20131319","journal-title":"Nat Med"},{"issue":"2","key":"2_CR53","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1128\/JVI.01372-09","volume":"84","author":"M Mateo","year":"2010","unstructured":"Mateo M et al (2010) Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. J Virol 84(2):1169\u20131175","journal-title":"J Virol"},{"issue":"Suppl 3","key":"2_CR54","doi-asserted-by":"publisher","first-page":"S757","DOI":"10.1093\/infdis\/jir296","volume":"204","author":"ME Miranda","year":"2011","unstructured":"Miranda ME, Miranda NL (2011) Reston ebolavirus in humans and animals in the Philippines: a review. J Infect Dis 204(Suppl 3):S757\u2013S760","journal-title":"J Infect Dis"},{"issue":"3","key":"2_CR55","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1128\/jcm.20.3.486-489.1984","volume":"20","author":"SW Mitchell","year":"1984","unstructured":"Mitchell SW, McCormick JB (1984) Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol 20(3):486\u2013489","journal-title":"J Clin Microbiol"},{"issue":"12","key":"2_CR56","doi-asserted-by":"publisher","first-page":"e1003065","DOI":"10.1371\/journal.ppat.1003065","volume":"8","author":"GS Mohan","year":"2012","unstructured":"Mohan GS et al (2012) Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus. PLoS Pathog 8(12):e1003065","journal-title":"PLoS Pathog"},{"issue":"15","key":"2_CR57","doi-asserted-by":"publisher","first-page":"8327","DOI":"10.1128\/JVI.01025-13","volume":"87","author":"S Moller-Tank","year":"2013","unstructured":"Moller-Tank S et al (2013) Role of the Phosphatidylserine receptor TIM-1 in enveloped-virus entry. J Virol 87(15):8327\u20138341","journal-title":"J Virol"},{"issue":"3","key":"2_CR58","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1128\/JVI.73.3.2333-2342.1999","volume":"73","author":"E Muhlberger","year":"1999","unstructured":"Muhlberger E et al (1999) Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J Virol 73(3):2333\u20132342","journal-title":"J Virol"},{"issue":"10","key":"2_CR59","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1128\/JVI.76.10.4855-4865.2002","volume":"76","author":"T Noda","year":"2002","unstructured":"Noda T et al (2002) Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol 76(10):4855\u20134865","journal-title":"J Virol"},{"key":"2_CR60","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3389\/fmicb.2016.01765","volume":"7","author":"ML Pleet","year":"2016","unstructured":"Pleet ML et al (2016) Ebola VP40 in exosomes can cause immune cell dysfunction. Front Microbiol 7:1765","journal-title":"Front Microbiol"},{"key":"2_CR88","doi-asserted-by":"crossref","unstructured":"Pleet ML et al (2019) Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion. Viruses 11(5):410","DOI":"10.3390\/v11050410"},{"issue":"7","key":"2_CR61","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1128\/JVI.01875-08","volume":"83","author":"KC Prins","year":"2009","unstructured":"Prins KC et al (2009) Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J Virol 83(7):3069\u20133077","journal-title":"J Virol"},{"issue":"2","key":"2_CR62","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/jvi.36.2.465-469.1980","volume":"36","author":"RL Regnery","year":"1980","unstructured":"Regnery RL et al (1980) Virion nucleic acid of Ebola virus. J Virol 36(2):465\u2013469","journal-title":"J Virol"},{"issue":"11","key":"2_CR63","doi-asserted-by":"publisher","first-page":"5156","DOI":"10.1128\/JVI.02349-05","volume":"80","author":"SP Reid","year":"2006","unstructured":"Reid SP et al (2006) Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol 80(11):5156\u20135167","journal-title":"J Virol"},{"issue":"5","key":"2_CR64","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/BF01718165","volume":"141","author":"E Ryabchikova","year":"1996","unstructured":"Ryabchikova E et al (1996) Ebola virus infection in Guinea pigs: presumable role of granulomatous inflammation in pathogenesis. Arch Virol 141(5):909\u2013921","journal-title":"Arch Virol"},{"issue":"Suppl 1","key":"2_CR65","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1086\/514293","volume":"179","author":"EI Ryabchikova","year":"1999","unstructured":"Ryabchikova EI et al (1999) An analysis of features of pathogenesis in two animal models of Ebola virus infection. J Infect Dis 179(Suppl 1):S199\u2013S202","journal-title":"J Infect Dis"},{"issue":"3","key":"2_CR66","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0168-1702(93)90063-S","volume":"29","author":"A Sanchez","year":"1993","unstructured":"Sanchez A et al (1993) Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res 29(3):215\u2013240","journal-title":"Virus Res"},{"issue":"8","key":"2_CR67","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","volume":"93","author":"A Sanchez","year":"1996","unstructured":"Sanchez A et al (1996) The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A 93(8):3602\u20133607","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"2_CR68","doi-asserted-by":"publisher","first-page":"10370","DOI":"10.1128\/JVI.78.19.10370-10377.2004","volume":"78","author":"A Sanchez","year":"2004","unstructured":"Sanchez A et al (2004) Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 78(19):10370\u201310377","journal-title":"J Virol"},{"issue":"12","key":"2_CR69","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1016\/S0021-9258(18)60636-2","volume":"263","author":"RR Schleef","year":"1988","unstructured":"Schleef RR et al (1988) Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 263(12):5797\u20135803","journal-title":"J Biol Chem"},{"issue":"17","key":"2_CR70","doi-asserted-by":"publisher","first-page":"8993","DOI":"10.1128\/JVI.00523-09","volume":"83","author":"M Sch\u00fcmann","year":"2009","unstructured":"Sch\u00fcmann M et al (2009) Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J Virol 83(17):8993\u20138997","journal-title":"J Virol"},{"issue":"5","key":"2_CR71","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1128\/jvi.76.5.2518-2528.2002","volume":"76","author":"G Simmons","year":"2002","unstructured":"Simmons G et al (2002) Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol 76(5):2518\u20132528","journal-title":"J Virol"},{"issue":"24","key":"2_CR72","doi-asserted-by":"publisher","first-page":"13433","DOI":"10.1128\/JVI.77.24.13433-13438.2003","volume":"77","author":"G Simmons","year":"2003","unstructured":"Simmons G et al (2003) Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol 77(24):13433\u201313438","journal-title":"J Virol"},{"issue":"1","key":"2_CR73","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1128\/JVI.79.1.547-553.2005","volume":"79","author":"NJ Sullivan","year":"2005","unstructured":"Sullivan NJ et al (2005) Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. J Virol 79(1):547\u2013553","journal-title":"J Virol"},{"issue":"4","key":"2_CR74","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1128\/JVI.72.4.3155-3160.1998","volume":"72","author":"RJ Wool-Lewis","year":"1998","unstructured":"Wool-Lewis RJ, Bates P (1998) Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 72(4):3155\u20133160","journal-title":"J Virol"},{"key":"2_CR75","unstructured":"World Health Organization (2016) Situation report, Ebola virus disease. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/208883\/ebolasitrep_10Jun2016_eng.pdf;jsessionid=8B7D74BC9D82D2BE1B110BAFFAD3A6E6?sequence=1"},{"key":"2_CR76","unstructured":"World Health Organization (2016) Final trial results confirm Ebola vaccine provides high protection against disease. https:\/\/www.who.int\/en\/news-room\/detail\/23-12-2016-final-trial-results-confirm-ebola-vaccine-provides-high-protection-against-disease"},{"key":"2_CR77","unstructured":"World Health Organization (2019) https:\/\/www.who.int\/news-room\/detail\/17-07-2019-ebola-outbreak-in-the-democratic-republic-of-the-congo-declared-a-public-health-emergency-of-international-concern"},{"issue":"8","key":"2_CR78","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/78654","volume":"6","author":"ZY Yang","year":"2000","unstructured":"Yang ZY et al (2000) Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 6(8):886\u2013889","journal-title":"Nat Med"},{"issue":"18","key":"2_CR79","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.1128\/JVI.77.18.9987-9992.2003","volume":"77","author":"J Yasuda","year":"2003","unstructured":"Yasuda J et al (2003) Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol 77(18):9987\u20139992","journal-title":"J Virol"},{"issue":"21","key":"2_CR80","doi-asserted-by":"publisher","first-page":"12500","DOI":"10.1128\/JVI.02163-14","volume":"88","author":"B Yen","year":"2014","unstructured":"Yen B et al (2014) Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation. J Virol 88(21):12500\u201312510","journal-title":"J Virol"},{"issue":"2","key":"2_CR81","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1128\/JVI.79.2.918-926.2005","volume":"79","author":"A Yonezawa","year":"2005","unstructured":"Yonezawa A et al (2005) Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J Virol 79(2):918\u2013926","journal-title":"J Virol"},{"issue":"11","key":"2_CR82","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s13238-015-0220-y","volume":"6","author":"S Yuan","year":"2015","unstructured":"Yuan S et al (2015) TIM-1 acts a dual-attachment receptor for Ebolavirus by interacting directly with viral GP and the PS on the viral envelope. Protein Cell 6(11):814\u2013824","journal-title":"Protein Cell"},{"key":"2_CR83","first-page":"97","volume":"235","author":"SR Zaki","year":"1999","unstructured":"Zaki SR, Goldsmith CS (1999) Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol 235:97\u2013116","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"2_CR84","doi-asserted-by":"publisher","first-page":"e1002550","DOI":"10.1371\/journal.ppat.1002550","volume":"8","author":"AP Zhang","year":"2012","unstructured":"Zhang AP et al (2012) The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold. PLoS Pathog 8(2):e1002550","journal-title":"PLoS Pathog"}],"container-title":["Advances in Experimental Medicine and Biology","Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-67452-6_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T06:09:36Z","timestamp":1649830176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-67452-6_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030674519","9783030674526"],"references-count":85,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-67452-6_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"19 October 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}